Abstract
Bioassay and dosometry models are needed to estimate intakes of radionuclides, and to calculate radiation doses to target tissues following such in takes. Because of the diversity of exposure materials, individual biological variabilities, and the general lack of adequate bioassay information and knowledge of the metabolism of radionuclides, current models are based mostly on empiricism. This paper describes biokinetic/dosimetry models for U, Am, and Cm. They are based on experimental data developed from studies in dogs that inhaled one of the above radionuclides in specific chemical forms and specific particle sizes. The models, which are based on similar biological principles, and, therefore, have similar structure, are applied to the very sparse human bioassay data available from cases of exposure to either U, Am, or Cm. The results thus far indicate that the lung retention for the different actinides are well described by the models, that urinary bioassay data can be described within limited time periods, and that the fecal excretion rate is not adequately described. Improvements in modeling are predicted on increased publication of human bioassay data, and better cooperative interaction between model developers and health protection professionals responsible for industrial bioassay programs.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Radioanalytical and Nuclear Chemistry Articles
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
